Obesity in men could dictate future colon screenings

February 4, 2014

Obesity is a known risk factor for many cancers including colon cancer, yet the reasons behind the colon cancer link have often remained unclear.

A Michigan State University study is shedding more light on the topic and has shown that elevated leptin – a fat hormone – higher and a larger waistline in men is associated with a greater likelihood of having , precancerous growths linked to .

The result may put men at an even greater risk of the disease and also may mean their body weight could eventually be a deciding factor in whether a colonoscopy is in their future. Today, age and family history typically dictate a screening.

Jenifer Fenton, assistant professor and researcher in the Department of Food Science and Human Nutrition, and Kari Hortos, associate dean in MSU's College of Osteopathic Medicine at the Macomb University Center, led the 18-month, cross-sectional study, which followed 126 healthy, white American males ranging from 48 to 65 years of age. Participants showed no signs or symptoms of health issues, yet underwent routine colonoscopies.

"What we found is 78 percent of the 126 men in the study were either overweight or obese based on their BMI or waist circumference. Of those, about 30 percent were found to have more than one polyp after colonoscopies were performed," said Fenton. "In fact, the more obese participants were 6.5 times more likely to have three polyps compared to their thinner counterparts."

Sarah Comstock, a co-author of the study and research fellow in the Department of Food Science and Human Nutrition, also indicated that the significance of the research is twofold.

"Not only does it show the association that leptin and a higher BMI have with , but it gives us a better snapshot on how and other factors may actually help us determine who might be at a higher risk of developing polyps," she said.

With obesity rates climbing during the past 20 years within the United States and colon cancer being the second-leading killer of men and women in the nation, these facts compelled Fenton and her team to conduct research which could identify the specific biomarkers of obesity and early-stage colon cancer and help in prevention efforts.

Previous research published by Fenton in 2009 identified the connection between obesity and colon cancer through examining tissue hormones. These studies demonstrated that, at higher levels, leptin worked as a primary mechanism in inducing precancerous colon cells by increasing the blood supply to them and promoting their progression.

"Even with all of our research, there's still more to be done, particularly in larger, more diverse populations, before any changes in screening recommendations can be made," said Fenton. "But we've definitely got a good start."

The study was recently published in the online journal PLOS ONE.

Explore further: Too much sitting tied to higher risk of colon polyps in men

More information: www.plosone.org/article/info%3 … journal.pone.0085939

Related Stories

Too much sitting tied to higher risk of colon polyps in men

October 28, 2013
(HealthDay)—Men who are more sedentary face a higher risk of recurring colon polyps, according to a new study, even if these men break up their downtime with bouts of recreational activities such as walking, jogging or ...

Radiographic imaging exposes relationship between obesity and cancer

December 4, 2013
Researchers at the National Institute for Aging are working to improve understanding about obesity and cancer. A study, published today in the journal Applied Physiology, Nutrition, and Metabolism, is the first to use direct ...

Obese white women less likely to seek colon cancer screening

April 4, 2012
A new study by Johns Hopkins researchers shows that obese white women may be less likely than normal-weight counterparts and African-Americans of any weight or gender to seek potentially lifesaving colon cancer screening ...

Colon cancer screening guidelines may miss 10 percent of colon cancers

October 22, 2013
For people with a family history of adenomas (colon polyps that lead to colon cancer), up to 10 percent of colorectal cancers could be missed when current national screening guidelines are followed. Colorectal cancer is the ...

Blacks and Hispanics at higher risk for precancerous colorectal polyps

May 3, 2012
Blacks and Hispanics have a significantly higher risk of developing precancerous colorectal polyps compared with whites, according to a study by researchers at NewYork – Presbyterian Hospital/Columbia University Medical ...

Recommended for you

Could a green sponge hold cancer-fighting secrets?

July 27, 2017
A small green sponge discovered in dark, icy waters of the Pacific off Alaska could be the first effective weapon against pancreatic cancer, researchers said on Wednesday.

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.